Statins as a component of lipid-lowering therapy
| Autor: | Sergey N. Kozlov, Andrey V. Evseev, Andrey I. Danilov |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
business.industry Cholesterol Atorvastatin nutritional and metabolic diseases General Medicine medicine.disease chemistry.chemical_compound chemistry Simvastatin Internal medicine Hyperlipidemia polycyclic compounds Medicine lipids (amino acids peptides and proteins) Rosuvastatin cardiovascular diseases Lovastatin business Pravastatin medicine.drug Fluvastatin |
| Zdroj: | Reviews on Clinical Pharmacology and Drug Therapy. 17:79-82 |
| ISSN: | 2542-1875 1683-4100 |
| Popis: | Statins are the main class of drugs that are used to treat patients with hyperlipidemia and atherosclerosis. Over the past decades, dozens of randomized clinical trials with this group of drugs have been conducted. Their results showed a significant reduction in cardiovascular and overall mortality, regardless of gender, age, baseline cholesterol levels. Currently, 6 drugs of this class are registered in the Russian Federation: Atorvastatin, Lovastatin, Simvastatin, Pravastatin, Rosuvastatin and Fluvastatin. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|